References
1. Curtis C, Ogbogu P. Hypereosinophilic Syndrome. Clin Rev
Allergy Immunol . Apr 2016;50(2):240-51. doi:10.1007/s12016-015-8506-7
2. Ferruzzi V, Santi E, Gurdo G, Arcioni F, Caniglia M, Esposito S.
Acute Lymphoblastic Leukemia with Hypereosinophilia in a Child: Case
Report and Literature Review. Int J Environ Res Public Health .
Jun 4 2018;15(6)doi:10.3390/ijerph15061169
3. Song G, Liu H, Sun F, Gu L, Wang S. Acute lymphocytic leukemia with
eosinophilia: a case report and review of the literature. Aging
Clin Exp Res . Oct 2012;24(5):555-8. doi:10.3275/8337
4. Kaneko H, Shimura K, Yoshida M, et al. Acute lymphoblastic leukemia
with eosinophilia lacking peripheral blood leukemic cell: a rare entity.Indian J Hematol Blood Transfus . Sep 2014;30(Suppl 1):80-3.
doi:10.1007/s12288-013-0255-2
5. Ono R, Iwahana T, Kato H, Okada S, Kobayashi Y. Literature reviews of
stroke with hypereosinophilic syndrome. Int J Cardiol Heart Vasc .
Dec 2021;37:100915. doi:10.1016/j.ijcha.2021.100915
6. Hsieh FH. Hypereosinophilic syndrome. Ann Allergy Asthma
Immunol . Jun 2014;112(6):484-8. doi:10.1016/j.anai.2014.03.004
7. Valent P, Klion AD, Horny H-P, et al. Contemporary consensus proposal
on criteria and classification of eosinophilic disorders and related
syndromes. Journal of Allergy and Clinical Immunology .
2012/09/01/ 2012;130(3):607-612.e9.
doi:https://doi.org/10.1016/j.jaci.2012.02.019
8. Gotlib J. World Health Organization-defined eosinophilic disorders:
2017 update on diagnosis, risk stratification, and management. Am
J Hematol . Nov 2017;92(11):1243-1259. doi:10.1002/ajh.24880
9. Hill A, Metry D. Urticarial lesions in a child with acute
lymphoblastic leukemia and eosinophilia. Pediatr Dermatol .
Nov-Dec 2003;20(6):502-5. doi:10.1111/j.1525-1470.2003.20610.x
10. Chien AJ, Argenyi ZB, Colven RM, Kirby P. Acute lymphoblastic
leukemia presenting with urticarial plaques and hypereosinophilia in a
child. J Am Acad Dermatol . Nov 2004;51(5 Suppl):S151-5.
doi:10.1016/j.jaad.2004.04.018
11. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson
BH. NIH conference. The idiopathic hypereosinophilic syndrome. Clinical,
pathophysiologic, and therapeutic considerations. Ann Intern Med .
Jul 1982;97(1):78-92. doi:10.7326/0003-4819-97-1-78
12. Kahn JE, Groh M, Lefèvre G. (A Critical Appraisal of) Classification
of Hypereosinophilic Disorders. Front Med (Lausanne) . 2017;4:216.
doi:10.3389/fmed.2017.00216
13. Roufosse F. Hypereosinophilic syndrome variants: diagnostic and
therapeutic considerations. Haematologica . Sep
2009;94(9):1188-93. doi:10.3324/haematol.2009.010421
14. Guenzel AJ, Smadbeck JB, Golden CL, et al. Clinical utility of next
generation sequencing to detect IGH/IL3 rearrangements
[t(5;14)(q31.1;q32.1)] in B-lymphoblastic leukemia/lymphoma.Ann Diagn Pathol . Aug 2021;53:151761.
doi:10.1016/j.anndiagpath.2021.151761